Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "Zhe Sun"

  • Modify Search
  • Create Alert
  • Save Search

38 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 08/02/2017
e.g., 08/02/2017
Format Results
  • You have access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen, Victor Gurewich
    Circulation Research April 2002, 90 (7) 757-763; DOI: https://doi.org/10.1161/01.RES.0000014825.71092.BD
    View table
    Table 1.
    By Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Kinetics Analysis of S2444 Amidolysis by proUK, Single-Chain M5, UK, and tc-M5 and Glu-Plasminogen Activation by UK and tc-M5Show More
    Kinetics Analysis of S2444 Amidolysis by proUK, Single-Chain M5, UK, and tc-M5 and Glu-Plasminogen Activation by UK and tc-M5Show Less
  • You have access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen, Victor Gurewich
    Circulation Research April 2002, 90 (7) 757-763; DOI: https://doi.org/10.1161/01.RES.0000014825.71092.BD
    By Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Figure 1. Plasminogen activation by proUK (solid line) or M5 (broken line) from a mixture o...
    Show More
    Figure 1. Plasminogen activation by proUK (solid line) or M5 (broken line) from a mixture of Glu-plasminogen (2 μmol/L), S2251 (1.5 mmol/L), and proUK or M5 (0.075 nmol/L). The activity curve, taken from a microtiter plate reader, shows that compared with proUK, M5 has a longer lag phase but that this is followed by a much steeper slope, reflecting its more rapid tc reaction rate.
    Show Less
  • You have access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen, Victor Gurewich
    Circulation Research April 2002, 90 (7) 757-763; DOI: https://doi.org/10.1161/01.RES.0000014825.71092.BD
    View table
    Table 2.
    By Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Glu-Plasminogen (2 μmol/L) Activation by Plasmin-Resistant Ala158-oroUK or Ala158-M5 (1 nmol/L) in the Presence of CofactorsShow More
    Glu-Plasminogen (2 μmol/L) Activation by Plasmin-Resistant Ala158-oroUK or Ala158-M5 (1 nmol/L) in the Presence of CofactorsShow Less
  • You have access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen, Victor Gurewich
    Circulation Research April 2002, 90 (7) 757-763; DOI: https://doi.org/10.1161/01.RES.0000014825.71092.BD
    By Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Figure 2. In vitro lysis of 125I-labeled plasma clots (0.2 mL) in a plasma milie...
    Show More
    Figure 2. In vitro lysis of 125I-labeled plasma clots (0.2 mL) in a plasma milieu (4 mL) by M5 (0.5 to 5 μg/mL) (A) or proUK (0.5 to 1.5 μg/mL) (B) over a fibrin-specific (<25% fibrinogen degradation) dose range. The percent clot lysis was determined from the radioactivity released into the plasma. The maximal rate of lysis, as reflected by the steepest slope, was 64% per hour for M5 and 41% per hour for proUK.
    Show Less
  • You have access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen, Victor Gurewich
    Circulation Research April 2002, 90 (7) 757-763; DOI: https://doi.org/10.1161/01.RES.0000014825.71092.BD
    By Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Figure 3. In vivo lysis of 125I-labeled whole blood clots in the dog. The radioa...
    Show More
    Figure 3. In vivo lysis of 125I-labeled whole blood clots in the dog. The radioactivity in plasma samples (mean±SD) obtained at intervals is shown. The number of dogs in each group is shown in parentheses, and the infusate (saline, proUK, tPA, or M5) and infusion rate (μg/kg per minute) are indicated.
    Show Less
  • You have access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen, Victor Gurewich
    Circulation Research April 2002, 90 (7) 757-763; DOI: https://doi.org/10.1161/01.RES.0000014825.71092.BD
    By Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Figure 4. BT (mean±SD) in dogs (number in parentheses) infused with saline, tPA, proUK, or...
    Show More
    Figure 4. BT (mean±SD) in dogs (number in parentheses) infused with saline, tPA, proUK, or M5 (60 μg/kg per minute).
    Show Less
  • You have access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen, Victor Gurewich
    Circulation Research April 2002, 90 (7) 757-763; DOI: https://doi.org/10.1161/01.RES.0000014825.71092.BD
    By Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Figure 5. Total bleeding (mean±SD), as measured by the total number of gauze pads used to a...
    Show More
    Figure 5. Total bleeding (mean±SD), as measured by the total number of gauze pads used to absorb the blood from the BT wounds in the dogs infused with saline, tPA, proUK, or M5.
    Show Less
  • You have access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen, Victor Gurewich
    Circulation Research April 2002, 90 (7) 757-763; DOI: https://doi.org/10.1161/01.RES.0000014825.71092.BD
    By Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Figure 6. Clot lysis, fibrinogen, and BT in 4 monkeys infused with M5 (60 μg/kg per minute)...
    Show More
    Figure 6. Clot lysis, fibrinogen, and BT in 4 monkeys infused with M5 (60 μg/kg per minute). The mean±SD values at baseline (0), 30, 45, and 60 minutes are shown. The results are presented as a percentage of the baseline (0% or 100%) value. The 2 saline-infused monkeys had ≈8% clot lysis at 60 minutes (not shown).
    Show Less
  • You have accessRestricted access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Circulation Research. 2002;90:757-763, originally published March 7, 2002
    https://doi.org/10.1161/01.RES.0000014825.71092.BD
    Download PDF
  • You have access
    Prourokinase Mutant That Induces Highly Effective Clot Lysis Without Interfering With Hemostasis
    Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen, Victor Gurewich
    Circulation Research April 2002, 90 (7) 757-763; DOI: https://doi.org/10.1161/01.RES.0000014825.71092.BD
    View table
    Table 1.
    By Jian-Ning Liu, Jian-Xia Liu, Bei-fang Liu, Ziyong Sun, Jian-Ling Zuo, Pei-xiang Zhang, Jing Zhang, Yu-hong Chen and Victor Gurewich
    Kinetics Analysis of S2444 Amidolysis by proUK, Single-Chain M5, UK, and tc-M5 and Glu-Plasminogen Activation by UK and tc-M5Show More
    Kinetics Analysis of S2444 Amidolysis by proUK, Single-Chain M5, UK, and tc-M5 and Glu-Plasminogen Activation by UK and tc-M5Show Less

Pages

  • 1
  • 2
  • 3
  • 4
  • Next Page
Back to top

Selected Facets

Selected Facets

  • 1978 - 2002 (Publication date)

Journal

Source

  • Circulation Research 35
  • Circulation 3

Article Type

Article Type

  • Article 6
  • Fibrinolysis 8
  • Genetics of cardiovascular disease 7
  • Integrative Physiology 15
  • Lipid and lipoprotein metabolism 7
  • Mechanism of atherosclerosis/growth factors 7
  • Molecular Medicine 17
  • Research Support, Non-U.S. Gov't 2
  • Research Support, U.S. Gov't, Non-P.H.S. 1
  • Research Support, U.S. Gov't, P.H.S. 4
  • Show More
  • Show Less

Subject

Subject

  • Fibrinolysis 17
  • Genetics of cardiovascular disease 15
  • Lipid and lipoprotein metabolism 15
  • Mechanism of atherosclerosis/growth factors 15

Content Type

Resource Type

  • Articles 8
  • Tables & Figures 28
  • HWTABLE 2
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured